The Race for Hydroxamate-Based Zirconium-89 Chelators

The Race for Hydroxamate-Based Zirconium-89 Chelators

Metallic radionuclides conjugated to biological vectors via an appropriate chelator are employed in nuclear medicine for the diagnosis (imaging) and radiotherapy of diseases. For the application of radiolabeled antibodies using positron emission tomography (immunoPET), zirconium-89 has gained increa...

Full description

Bibliographic Details
Main Authors: Irene V. J. Feiner, Marie Brandt, Joseph Cowell, Tori Demuth, Daniëlle Vugts, Gilles Gasser, Thomas L. Mindt
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
hydroxamate chelators
zirconium-89
immunoPET
desferrioxamine
DFO
Online Access:https://www.mdpi.com/2072-6694/13/17/4466

Internet

https://www.mdpi.com/2072-6694/13/17/4466

Similar Items